...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM webcast 9/12/2018

I found the link on the website...listening to it now....just as exciting as RVX...for us early guys back in 2006 and beyond...we have a bonanza to look forward to in 2019-2022...Wow!

Share
New Message
Please login to post a reply